Search

Pulse Biosciences Inc

Ouvert

SecteurSoins de santé

48.95 -1.17

Résumé

Variation du prix de l'action

24h

Actuel

Min

49.05

Max

49.75

Chiffres clés

By Trading Economics

Revenu

-6.1M

-25M

Ventes

33K

434K

BPA

-0.36

Marge bénéficiaire

-5,681.336

Employés

116

EBITDA

-5.8M

-25M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+13.57% upside

Dividendes

By Acuity

Prochains Résultats

4 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

991M

3.6B

Ouverture précédente

50.12

Clôture précédente

48.95

Sentiment de l'Actualité

By Acuity

61%

39%

274 / 340 Classement par Healthcare

Pulse Biosciences Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

5 oct. 2026, 20:06 UTC

Pulse Biosciences Inc is advancing, continuing its upward trend since Friday, despite an earlier pullback from a session high. The health care equipment sector shows notable gains.

2 oct. 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, closing at their lowest point amid broader market weakness and trading below the 20-day moving average.

1 oct. 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, pulling back from a morning peak and remaining below its 20-day moving average.

30 sept. 2026, 21:01 UTC

Pulse Biosciences Inc closed lower in after-market trading, marking its fourth consecutive session of decline and remaining significantly below its 20-day moving average.

29 sept. 2026, 21:21 UTC

Pulse Biosciences Inc has declined in after-market trading, moving lower since Tuesday's close and falling below its 20-day moving average.

28 sept. 2026, 22:21 UTC

Pulse Biosciences Inc saw a significant increase in after-market trading, reaching a notable peak and remaining well above its 20-day moving average.

25 sept. 2026, 20:07 UTC

Pulse Biosciences Inc shares fell modestly as the broader market declined, continuing a trend of five consecutive sessions finishing lower.

24 sept. 2026, 20:07 UTC

Pulse Biosciences Inc. shares fell sharply, continuing a trend of declines over the last four sessions after an earlier gain in the current session.

23 sept. 2026, 19:25 UTC

Pulse Biosciences Inc shares fell modestly, continuing a downward trend observed over the past three sessions, despite initially rising sharply after the market opened.

22 sept. 2026, 19:34 UTC

Pulse Biosciences Inc shares fell sharply, declining from Monday's close despite remaining above the 20-day moving average and within the one-month range.

21 sept. 2026, 20:12 UTC

Pulse Biosciences Inc declined in after-market trading following Monday's close, remaining flat throughout the session but positioned above its 20-day moving average.

18 sept. 2026, 20:02 UTC

Pulse Biosciences Inc shares are rising sharply, reaching a notable high and trading above its 20-day moving average with unusually high volume.

17 sept. 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16 sept. 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 sept. 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14 sept. 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11 sept. 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 sept. 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 sept. 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

8 sept. 2026, 23:31 UTC

Pulse Biosciences Inc shares are higher in after-market trading, recovering significantly and nearing the upper end of their one-month range.

4 sept. 2026, 22:26 UTC

Pulse Biosciences Inc. shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

3 sept. 2026, 22:21 UTC

Pulse Biosciences Inc shares are lower in after-market hours amid notable volatility, reversing gains from the previous four sessions without specific news to explain the decline.

2 sept. 2026, 23:41 UTC

Pulse Biosciences Inc shares are higher in after-market hours, recovering from earlier losses amid broader market strength following weaker job growth data from ADP.

1 sept. 2026, 22:51 UTC

Pulse Biosciences Inc shares are higher in after-market trading, following earlier volatility amid macroeconomic pressures and a mixed sentiment in the health care equipment sector.

31 août 2026, 20:07 UTC

Pulse Biosciences is trading higher, reflecting broader market gains since Friday. The stock remains above its 20-day moving average and near its one-month range.

29 août 2026, 00:01 UTC

Pulse Biosciences Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the top of its one-month range.

28 août 2026, 23:46 UTC

Pulse Biosciences Inc is trading lower in after-market hours, with no specific news identified to explain the movement. Broader market conditions may be influencing sentiment.

27 août 2026, 20:07 UTC

News

Pulse Biosciences Inc. is higher today, recovering from a prior session decline. Analyst Mike Matson has a Buy rating and $58 price target.

26 août 2026, 23:21 UTC

Pulse Biosciences Inc is higher in after-market trading, reflecting a broader market trend. The price remains near the upper end of its one-month range.

25 août 2026, 20:07 UTC

Shares of Pulse Biosciences Inc. are lower today, reflecting routine volatility amid a broader market backdrop of declining oil prices and Treasury yields.

Comparaison

Variation de prix

Pulse Biosciences Inc prévision

Objectif de Prix

By TipRanks

13.57% hausse

Prévisions sur 12 Mois

Moyen 56.5 USD  13.57%

Haut 73 USD

Bas 35 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

6

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

274 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.